How to get the most out of Valeant Pharmaceuticals stock

The stock is still up more than 20% over the past year but Valeant shares are down more than 30% from their recent peak.Investors are betting Valeant is going to lose its position in the world’s largest generic drugmaker.The stock was up almost 17% last year before Valeant was hit with a recall of about…

Read More